لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Seefat MR; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī., Stege CAM; Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlandsī., Lissenberg-Witte BI; Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Levin MD; Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Timmers GJ; Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., Hoogendoorn M; Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Ypma PF; Hematology, Haga Hospital, Den Haag, the Netherlands., Klein SK; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands., Velders GA; Internal Medicine, Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Westerman M; Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., Strobbe L; Internal Medicine, Gelre Hospital Zutphen, Zutphen, the Netherlands., Durdu-Rayman N; Internal Medicine, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., Davidis-van Schoonhoven MA; Internal Medicine, Beatrix Hospital, Gorinchem, the Netherlands., van Kampen RJW; Internal Medicine-hematology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Dijk AC; Internal Medicine, St Jansdal Hospital, Harderwijk, the Netherlands., Koster A; Internal Medicine, Viecuri Medical Center, Venlo, the Netherlands., Silbermann MH; Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., van der Spek E; Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., Beeker A; Internal Medicine, MBA Spaarne Gasthuis, Hoofddorp, the Netherlands., Erjavec Z; Internal Medicine, Treant ziekenhuis, Hoogeveen, the Netherlands., de Graauw NCHP; Internal Medicine, Bravis ziekenhuis, Roosendaal, the Netherlands., Leys MBL; Hematology and Oncology, Maasstad ziekenhuis, Rotterdam, the Netherlands., Sonneveld P; Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlandsī., van de Donk NWCJ; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī., Nasserinejad K; Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlandsī., Blommestein HM; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands., Cucchi DGJ; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī; Internal Medicine, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., Zweegman S; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī. Electronic address: s.zweegman@amsterdamumc.nl.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114153. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/psychology , Quality of Life* , Bortezomib*/therapeutic use , Bortezomib*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Frailty*, Humans ; Aged ; Male ; Female ; Prospective Studies ; Aged, 80 and over ; Melphalan/administration & dosage ; Melphalan/adverse effects ; Melphalan/therapeutic use ; Prednisone/administration & dosage ; Prednisone/therapeutic use ; Prednisone/adverse effects ; Frail Elderly

المؤلفون: Luu IHY; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Appelboom Y; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Willems JIA; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Gielen RCAM; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Lobbes MBI; Department of Medical Imaging, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Külcü K; Department of Medical Imaging, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Ten Cate H; Department of Internal Medicine and Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands., Peeters J; General practice Overhoven-Hoogveld, Huisartsen Coöperatie Westelijke Mijnstreek, Sittard, the Netherlands., Palmen J; General practice Aarveld Medical Center, Huisartsen Oostelijk Zuid-Limburg, Heerlen, the Netherlands., Buijs J; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Jie KG; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Mostard GJM; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., van Twist DJL; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands. Electronic address: d.vantwist@zuyderland.nl.

المصدر: Thrombosis research [Thromb Res] 2024 Aug; Vol. 240, pp. 109059. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2472 (Electronic) Linking ISSN: 00493848 NLM ISO Abbreviation: Thromb Res Subsets: MEDLINE

مواضيع طبية MeSH: Venous Thrombosis*/drug therapy , Venous Thrombosis*/diagnosis , Heparin, Low-Molecular-Weight*/therapeutic use , Heparin, Low-Molecular-Weight*/administration & dosage , Anticoagulants*/therapeutic use , Anticoagulants*/administration & dosage, Humans ; Prospective Studies ; Female ; Male ; Middle Aged ; Aged ; Administration, Oral ; Aged, 80 and over ; Adult

المؤلفون: Bruggen JACV; 2Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands, Netherlands., Peters FS; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands, Netherlands., Mes MJ; Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, The Netherlands, Amsterdam, Netherlands., Rietveld JM; Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, Amsterdam, Netherlands., Cerretani E; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, The Netherlands, Amsterdam, Netherlands., Cretenet G; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands, Netherlands., van Kampen RJW; Zuyerland Medical Center, Sittard-Geleen, Netherlands., Jongejan A; Amsterdam University Medical Centers, Location AMC, Amsterdam, Netherlands., Moerland PDD; Amsterdam UMC, Amsterdam, Netherlands., Melenhorst JJ; Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States., Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands, Netherlands., Kater AP; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands, Netherlands.

المصدر: Blood advances [Blood Adv] 2024 Jul 23. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

المؤلفون: Groen K; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Smits F; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Nasserinejad K; HOVON Foundation Rotterdam The Netherlands.; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Levin MD; Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands., Regelink JC; Department of Internal Medicine Meander Medical Centre Amersfoort The Netherlands., Timmers GJ; Department of Internal Medicine Amstelland Hospital Amstelveen The Netherlands., de Waal EGM; Department of Internal Medicine Medical Centre Leeuwarden Leeuwarden The Netherlands., Westerman M; Department of Internal Medicine Northwest Clinics Alkmaar The Netherlands., Velders GA; Department of Internal Medicine Gelderse Vallei Ede The Netherlands., de Heer K; Department of Internal Medicine Flevoziekenhuis Almere The Netherlands., Leys RBL; Department of Internal Medicine Maasstad Hospital Rotterdam The Netherlands., van Kampen RJW; Department of Internal Medicine Zuyderland Hospital Sittard-Geleen The Netherlands., Stege CAM; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands.; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Seefat MR; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Nijhof IS; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Department of Internal Medicine Antonius Ziekenhuis Nieuwegein The Netherlands., van der Spek E; Department of Internal Medicine Rijnstate Hospital Arnhem The Netherlands., Klein SK; Department of Internal Medicine Meander Medical Centre Amersfoort The Netherlands.; Department of Hematology University Medical Center Groningen Groningen The Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Ypma PF; Department of Hematology Hagaziekenhuis, Den Haag The Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands.

المصدر: HemaSphere [Hemasphere] 2024 Jul 04; Vol. 8 (7), pp. e85. Date of Electronic Publication: 2024 Jul 04 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Luu IHY; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Mostard GJM; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., van Mil D; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., van Berlo MHW; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Lobbes MBI; Department of Medical Imaging, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Külcü K; Department of Medical Imaging, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Cate HT; Department of Internal Medicine and Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands., Peeters J; General practice Overhoven-Hoogveld, Huisartsen Coöperatie Westelijke Mijnstreek, Sittard, the Netherlands., Palmen J; General practice Aarveld Medical Center, Huisartsen Oostelijk Zuid-Limburg, Heerlen, the Netherlands., Buijs J; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., Jie KG; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands., van Twist DJL; Department of Internal Medicine, Zuyderland Medical Center, Sittard/Heerlen, the Netherlands. Electronic address: d.vantwist@zuyderland.nl.

المصدر: European journal of internal medicine [Eur J Intern Med] 2024 Apr; Vol. 122, pp. 54-60. Date of Electronic Publication: 2023 Dec 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9003220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0828 (Electronic) Linking ISSN: 09536205 NLM ISO Abbreviation: Eur J Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Venous Thrombosis*/diagnostic imaging , Venous Thrombosis*/drug therapy , Pulmonary Embolism*/complications, Humans ; Anticoagulants/adverse effects ; Retrospective Studies ; Critical Pathways

المؤلفون: van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.vandeloosdrecht@amsterdamumc.nl., Cremers EMP; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Alhan C; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Duetz C; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., In 't Hout FEM; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Visser-Wisselaar HA; HOVON Foundation, Rotterdam, The Netherlands., Chitu DA; HOVON Foundation, Rotterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Verbrugge A; HOVON Foundation, Rotterdam, The Netherlands., Cunha SM; HOVON Foundation, Rotterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Janssen JJWM; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Klein SK; Department of Hematology, Meander Medisch Centrum, Amersfoort, The Netherlands.; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Vellenga E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Muus P; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Haematology, St. James University Hospital, Leeds, UK., Langemeijer SMC; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., de Greef GE; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Te Boekhorst PAW; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Raaijmakers MHG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Marwijk Kooy M; Department of Hematology, Isala Ziekenhuis, Zwolle, The Netherlands., Legdeur MC; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Wegman JJ; Department of Hematology, Deventer Ziekenhuis, Deventer, The Netherlands.; Department of Hematology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands., Deenik W; Department of Internal Medicine, Tergooi Ziekenhuis, Hilversum, The Netherlands.; Department of Internal Medicine, Rijnstate, Arnhem, the Netherlands., de Weerdt O; Department of Internal Medicine, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands., van Maanen-Lamme TM; Department of Internal Medicine, Dijklander Ziekenhuis, Hoorn, The Netherlands., Jobse P; Department of Internal Medicine, Admiraal de Ruyter Ziekenhuis, Goes, The Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Ziekenhuis, Geleen, The Netherlands., Beeker A; Department of Hematology, Spaarne Gasthuis, Hoofddorp, The Netherlands., Wijermans PW; Department of Hematology, Haaglanden Ziekenhuis, Den Haag, The Netherlands., Biemond BJ; Department of Hematology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands., Tanis BC; Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, The Netherlands.; Department of General Practice Erasmus MC, Rotterdam, The Netherlands., van Esser JWJ; Department of Internal Medicine, Amphia Ziekenhuis, Breda, The Netherlands., Schaar CG; Department of Internal Medicine, Gelre Ziekenhuis, Apeldoorn, The Netherlands., Noordzij-Nooteboom HS; Department of Internal Medicine, Van Weel Bethesda Ziekenhuis, Dirksland, The Netherlands., Jacobs EMG; Department of Internal Medicine, Elkerliek Ziekenhuis, Helmond, The Netherlands., de Graaf AO; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Stevens-Kroef MJPL; Department of human genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Westers TM; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jansen JH; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.

المصدر: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 840-850. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Clinical Trial, Phase II; Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Hematinics*/pharmacology , Myelodysplastic Syndromes*/drug therapy , Myelodysplastic Syndromes*/genetics, Humans ; Lenalidomide/pharmacology ; Erythropoiesis ; Granulocyte Colony-Stimulating Factor/pharmacology ; Chromosome Deletion ; Chromosomes, Human, Pair 5/genetics ; Treatment Outcome

المؤلفون: Groen K; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands., Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Innovative Statistical Consulting, Therapeutics Development Team, Cytel Inc., Massachusetts, USA., de Heer K; Department of Internal Medicine, Flevoziekenhuis, Almere, the Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Hospital, Sittard-Geleen, the Netherlands., Leys RBL; Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands., Thielen N; Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands., Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., Wu KL; Department of Hematology, ZNA Stuivenberg, Antwerpen, Belgium., Ludwig I; Department of Internal Medicine, Ziekenhuis Bernhoven, Uden, the Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands., Velders GA; Department of Internal Medicine, Gelderse Vallei, Ede, the Netherlands., Vekemans MC; Department of Hematology, Cliniques Universitaires Saint-Luc, UCL, Brussels, Belgium., Timmers GJ; Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, the Netherlands., Tick LW; Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands., Verbrugge A; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Buitenhuis D; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Cunha SM; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., de Waal EGM; Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands., Sohne M; Department of Internal Medicine, Antonius Ziekenhuis, Nieuwegein, the Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Nijhof IS; Department of Internal Medicine, Antonius Ziekenhuis, Nieuwegein, the Netherlands., Klein SK; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands.; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Ypma PF; Department of Internal Medicine, Haga Hospital, Den Haag, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands.

المصدر: EClinicalMedicine [EClinicalMedicine] 2023 Aug 29; Vol. 63, pp. 102167. Date of Electronic Publication: 2023 Aug 29 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

المؤلفون: Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. c.stege@amsterdamumc.nl., Nasserinejad K; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Klein SK; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands.; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Timmers GJ; Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Ypma PF; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Nijhof IS; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Velders GA; Department of Internal Medicine, Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Strobbe L; Department of Internal Medicine, Gelre Hospital, Zutphen, the Netherlands., Durdu-Rayman N; Department of Internal Medicine-Hematology, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., Davidis-van Schoonhoven MA; Department of Internal Medicine, Beatrix Hospital, Gorinchem, the Netherlands., van Kampen RJW; Department of Internal Medicine/Hematology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Beeker A; Department of Internal Medicine, MBA Spaarne Gasthuis, Hoofddorp, the Netherlands., Koster A; Department of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands., Dijk AC; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., Leys RBL; Department of Hematology and Oncology, Maasstad Ziekenhuis, Rotterdam, the Netherlands., Silbermann MH; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., Groen K; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Burg-de Graauw NCHP; Department of Internal Medicine, Bravis ziekenhuis, Roosendaal, the Netherlands., Sinnige HAM; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, the Netherlands., van der Hem KG; Department of Internal Medicine, Zaans Medical Center, Zaandam, the Netherlands., Levenga H; Department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, the Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.

المصدر: Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2715-2719. Date of Electronic Publication: 2021 Feb 15.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Geriatric Assessment/*methods , Multiple Myeloma/*mortality, Aged ; Aged, 80 and over ; Follow-Up Studies ; Humans ; Multiple Myeloma/drug therapy ; Multiple Myeloma/pathology ; Prognosis ; Prospective Studies ; Survival Rate

المؤلفون: Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, the Netherlands., Kentos A; Department of Hematology, Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium., Sohne M; Department of Internal Medicine/Hematology, St Antonius Hospital, Nieuwegein, the Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Ludwig I; Department of Hematology, Bernhoven Hospital, Uden, the Netherlands., Thielen N; Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands., Durdu-Rayman N; Department of Internal Medicine-Hematology, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., de Graauw NCHP; Department of Internal Medicine, Bravis Hospital, Roosendaal, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., de Waal EGM; Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands., Vekemans MC; Department of Hematology, St Luc Hospital, Bruxelles, Belgium., Timmers GJ; Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Soechit S; Department of Hematology, Reinier de Graaf Groep, Delft, the Netherlands., Geerts PAF; Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands; Currently Isala, Zwolle, the Netherlands., Silbermann MH; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., Oosterveld M; Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands., Nijhof IS; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Klein SK; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Sep 01; Vol. 39 (25), pp. 2758-2767. Date of Electronic Publication: 2021 May 04.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Frail Elderly/*statistics & numerical data , Multiple Myeloma/*drug therapy, Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Boron Compounds/administration & dosage ; Dexamethasone/administration & dosage ; Female ; Follow-Up Studies ; Glycine/administration & dosage ; Glycine/analogs & derivatives ; Humans ; Male ; Multiple Myeloma/pathology ; Prognosis ; Prospective Studies ; Survival Rate